Cost-Effectiveness of Pioglitazone in Patients With Type 2 Diabetes and a History of Macrovascular Disease in a Swiss Setting. Swiss Med Wkly 2009, 139 (1112), 173-173. https://doi.org/10.4414/smw.2009.12381.